UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor–treated mice

Blood, 2001-12, Vol.98 (13), p.3520-3526

Björck, Pia

2001

Volltextzugriff (PDF)

APX005M, a CD40 agonist antibody with unique epitope specificity and Fc receptor binding profile for optimal therapeutic application

Cancer Immunology, Immunotherapy, 2021-07, Vol.70 (7), p.1853-1865

2021

Volltextzugriff (PDF)

Plasmacytoid Dendritic Cells Take Up Opsonized Antigen Leading to CD4+ and CD8+ T Cell Activation In Vivo

The Journal of immunology (1950), 2008-09, Vol.181 (6), p.3811-3817

2008

Volltextzugriff (PDF)

Dendritic cells exposed to herpes simplex virus in vivo do not produce IFN-alpha after rechallenge with virus in vitro and exhibit decreased T cell alloreactivity

The Journal of immunology (1950), 2004-05, Vol.172 (9), p.5396-5404

Bjoerck, Pia

2004

Volltextzugriff (PDF)

Cutting Edge: CD19+ Pro-B Cells Can Give Rise to Dendritic Cells In Vitro

The Journal of immunology (1950), 1998-12, Vol.161 (11), p.5795-5799

1998

Volltextzugriff (PDF)

Plasmacytoid dendritic cell dichotomy: identification of IFN-α producing cells as a phenotypically and functionally distinct subset

The Journal of immunology (1950), 2011-02, Vol.186 (3), p.1477-1485

2011

Volltextzugriff (PDF)

Human Interdigitating Dendritic Cells Induce Isotype Switching and IL-13-Dependent IgM Production in CD40-Activated Naive B Cells

The Journal of immunology (1950), 2000-02, Vol.164 (4), p.1847-1854

2000

Volltextzugriff (PDF)

Abstract 5004: APX005M, a humanized anti-CD40 antibody with strong immune-modulatory activities capable of tumor eradication in vivo

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.5004-5004

2016

Volltextzugriff (PDF)

Abstract 4867: The CD40 agonistic antibody APX005M ‘licenses’ antigen presenting cells to promote tumor-specific T-cell responses

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.4867-4867

2016

Volltextzugriff (PDF)

Human interdigitating dendritic cells directly stimulate CD40‐activated naive B cells

European journal of immunology, 1997-05, Vol.27 (5), p.1266-1274

1997

Volltextzugriff (PDF)

CD40 ligation counteracts Fas-induced apoptosis of human dendritic cells

International immunology, 1997-03, Vol.9 (3), p.365-372

1997

Volltextzugriff (PDF)

Plasmacytoid dendritic cell dichotomy: identification of interferon-α producing cells as a phenotypically and functionally distinct subset

The Journal of immunology (1950), 2010-12, Vol.186 (3), p.1477-1485

2010

Volltextzugriff (PDF)

Influenza A virus elevates active cathepsin B in primary murine DC

International immunology, 2007-05, Vol.19 (5), p.645-655

2007

Volltextzugriff (PDF)

Abstract 5546: A murine reactive version of TAK-573 (anti-CD38 attenuated IFNα fusion protein) shows immunomodulatory and antitumor activity, alone and in combination with standard-of-care agents, in IFNa-insensitive, immunocompetent murine multiple myeloma tumor models

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.5546-5546

2020

Volltextzugriff (PDF)

Plasmacytoid Dendritic Cells Take Up Opsonized Antigen Leading to CD4+ and CD8+ T Cell Activation In Vivo1

The Journal of immunology (1950), 2008-09, Vol.181 (6), p.3811-3817

2008

Volltextzugriff (PDF)

Dormant or defiant? Dendritic cells in CVID

Blood, 2004-10, Vol.104 (8), p.2213-2213

Bjoörck, Pia

2004

Volltextzugriff (PDF)

The multifaceted murine plasmacytoid dendritic cell

Human immunology, 2002-12, Vol.63 (12), p.1094-1102

Bjoerck, P

2002

Volltextzugriff (PDF)

CD40 ligation on human cord blood CD34+ hematopoietic progenitors induces their proliferation and differentiation into functional dendritic cells

The Journal of experimental medicine, 1997-01, Vol.185 (2), p.341-350

1997

Volltextzugriff (PDF)

A murine reactive version of TAK-573 (anti-CD38-targeted attenuated IFNα fusion protein) shows immunomodulatory and

Clinical lymphoma, myeloma and leukemia, 2019-10, Vol.19 (10), p.e116-e117

2019

Volltextzugriff (PDF)

Stimulation of CD40 in human bladder carcinoma cells inhibits anti‐FAS/APO‐1 (CD95)‐induced apoptosis

International journal of cancer, 1998-09, Vol.77 (6), p.849-853

1998

Volltextzugriff (PDF)

TAK-573, an anti-CD38-targeted attenuated interferon alpha (IFNα) fusion protein, showed anti-myeloma tumor responses in combination with standard of care (SOC) agents in multiple myeloma (MM) xenograft tumor models in vivo

Clinical lymphoma, myeloma and leukemia, 2019-10, Vol.19 (10), p.e116-e116

2019

Volltextzugriff (PDF)

Development of Dendritic Cells and Their Use in Tumor Therapy

Clinical Immunology, 1999-08, Vol.92 (2), p.119-127

Bjoerck, P

1999

Volltextzugriff (PDF)

Type 1 Polarized Dendritic Cells as Superior Therapeutic Vaccines Against Melanoma

Journal of immunotherapy (1997), 2004-11, Vol.27 (6), p.S22

2004

Volltextzugriff (PDF)

The CD40 agonistic monoclonal antibody APX005M has potent immune stimulatory capabilities

Journal for immunotherapy of cancer, 2015-11, Vol.3 (Suppl 2), p.P198-P198

2015

Volltextzugriff (PDF)

ITOC2 – 011. Identification of second-generation potent and selective inhibitors of indoleamine-2,3-dioxygenase-1 (IDO1) for the treatment of cancer

European journal of cancer (1990), 2015-03, Vol.51, p.S4-S4

2015

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(39)

Sprache

Englisch
(39)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor–treated mice

APX005M, a CD40 agonist antibody with unique epitope specificity and Fc receptor binding profile for optimal therapeutic application

Plasmacytoid Dendritic Cells Take Up Opsonized Antigen Leading to CD4+ and CD8+ T Cell Activation In Vivo

Dendritic cells exposed to herpes simplex virus in vivo do not produce IFN-alpha after rechallenge with virus in vitro and exhibit decreased T cell alloreactivity

Cutting Edge: CD19+ Pro-B Cells Can Give Rise to Dendritic Cells In Vitro

Plasmacytoid dendritic cell dichotomy: identification of IFN-α producing cells as a phenotypically and functionally distinct subset

Human Interdigitating Dendritic Cells Induce Isotype Switching and IL-13-Dependent IgM Production in CD40-Activated Naive B Cells

Abstract 5004: APX005M, a humanized anti-CD40 antibody with strong immune-modulatory activities capable of tumor eradication in vivo

Abstract 4867: The CD40 agonistic antibody APX005M ‘licenses’ antigen presenting cells to promote tumor-specific T-cell responses

Human interdigitating dendritic cells directly stimulate CD40‐activated naive B cells

CD40 ligation counteracts Fas-induced apoptosis of human dendritic cells

Plasmacytoid dendritic cell dichotomy: identification of interferon-α producing cells as a phenotypically and functionally distinct subset

Influenza A virus elevates active cathepsin B in primary murine DC

Abstract 5546: A murine reactive version of TAK-573 (anti-CD38 attenuated IFNα fusion protein) shows immunomodulatory and antitumor activity, alone and in combination with standard-of-care agents, in IFNa-insensitive, immunocompetent murine multiple myeloma tumor models

Plasmacytoid Dendritic Cells Take Up Opsonized Antigen Leading to CD4+ and CD8+ T Cell Activation In Vivo1

Dormant or defiant? Dendritic cells in CVID

The multifaceted murine plasmacytoid dendritic cell

CD40 ligation on human cord blood CD34+ hematopoietic progenitors induces their proliferation and differentiation into functional dendritic cells

A murine reactive version of TAK-573 (anti-CD38-targeted attenuated IFNα fusion protein) shows immunomodulatory and

Stimulation of CD40 in human bladder carcinoma cells inhibits anti‐FAS/APO‐1 (CD95)‐induced apoptosis

TAK-573, an anti-CD38-targeted attenuated interferon alpha (IFNα) fusion protein, showed anti-myeloma tumor responses in combination with standard of care (SOC) agents in multiple myeloma (MM) xenograft tumor models in vivo

Development of Dendritic Cells and Their Use in Tumor Therapy

Type 1 Polarized Dendritic Cells as Superior Therapeutic Vaccines Against Melanoma

The CD40 agonistic monoclonal antibody APX005M has potent immune stimulatory capabilities

ITOC2 – 011. Identification of second-generation potent and selective inhibitors of indoleamine-2,3-dioxygenase-1 (IDO1) for the treatment of cancer

Suchergebnisse filtern